Original Investigation

Shifts in Antipsychotic Prescribing by Clinician Type for Medicare Part D Beneficiaries, 2013-2023

JAMA Network Open 10.1001/jamanetworkopen.2026.3410

March 25, 2026 at 11:00 AM EDT

Read the full article

How have patterns of antipsychotic prescribing by clinician type changed among Medicare Part D beneficiaries from 2013 to 2023?In this repeated cross-sectional study, the proportion of antipsychotic prescriptions written by advanced practice registered nurses and physician assistants increased from 13.8% to 39.6%, making them the largest group of prescribers. During the same period, the proportion of antipsychotic prescriptions written by psychiatrists decreased from 48.4% to 32.4% and by primary care physicians from 33.0% to 23.8%.This study suggests that nonphysician clinicians now account for a larger proportion of antipsychotic prescribing among Medicare beneficiaries, indicating shifts in the mental health care workforce and prescribing practices.

Corresponding Author: Youngran Kim, PhD, Department of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston, 1200 Pressler St, Houston, TX 77030 (youngran.kim@uth.tmc.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks